Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.

Saved in:
Bibliographic Details
Title: Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.
Authors: Ibanez L; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA., Dube U; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA.; Medical Scientist Training Program, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA., Saef B; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA., Budde J; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA., Black K; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA., Medvedeva A; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA., Del-Aguila JL; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA., Davis AA; Department of Neurology, School of Medicine, Washington University in St Louis, Saint Louis, MO, USA., Perlmutter JS; Department of Neurology, School of Medicine, Washington University in St Louis, Saint Louis, MO, USA., Harari O; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA., Benitez BA; Department of Medicine, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA., Cruchaga C; Department of Psychiatry, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA. cruchagac@wustl.edu.; Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University in Saint Louis, Saint Louis, MO, USA. cruchagac@wustl.edu.
Source: BMC neurology [BMC Neurol] 2017 Nov 15; Vol. 17 (1), pp. 198. Date of Electronic Publication: 2017 Nov 15.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2377
DOI:10.1186/s12883-017-0978-z